Stock OXIS INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar OXIS International, Inc. Other OTC

Equities

US6918294025

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for OXIS International, Inc.
Mar. 26 GT Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 01 GT Biopharma to Conduct 1-for-30 Reverse Stock Split; Shares Fall MT

Chart calendar OXIS International, Inc.

49faf646320862e37e388ebc25bf614.fkzLU3ZbZ6vDiyV0Jz2OKwW9CM_oGJzKNMBTesirDj0.LnigNSRrEf-25EwmUVb3Xl__bf-OTteBXaMfL7L8b3MLfP0hIwEr-bfASg~55f98f7435e7c3d81492c2e0f2ff21a8

Upcoming events on OXIS International, Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-10-28 Q3 2024 Earnings Release (Projected)

Past events on OXIS International, Inc.

2023-12-18 02:00 pm Extraordinary Shareholders Meeting
2023-11-04 10:00 pm Society for Immunotherapy of Cancer Meeting - Abstract No:1180
2023-11-04 02:55 pm Society for Immunotherapy of Cancer Meeting - Abstract No:1180
2023-11-01 09:00 am Q3 2023 Earnings Release
2023-08-17 03:30 pm H.C. Wainwright Immune Cell Engager Conference
2023-08-07 09:00 am Q2 2023 Earnings Release
2023-06-28 02:00 pm Annual General Meeting
2023-05-24 ASTCT EBMT Joint Basic and Translational Scientific Meeting
2023-05-16 09:00 am PEGS Boston Conference
2023-05-15 05:00 pm Q1 2023 Earnings Release
2023-03-30 05:00 pm Q4 2022 Earnings Release
2023-02-28 09:00 am H.C. Wainwright Cell Therapy Virtual Conference
2022-12-12 06:00 pm American Society of Hematology Meeting - Abstract Number: 4623
2022-11-11 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract Number: 1204
2022-11-11 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract Number: 1202
2022-10-31 05:15 pm Q3 2022 Earnings Release
2022-10-26 07:30 pm LD Micro Main Event Conference
2022-10-10 02:00 pm Extraordinary Shareholders Meeting
2022-09-27 Extraordinary Shareholders Meeting
2022-09-13 10:30 am H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-6,76
-6,10
-10.89%		-57,5
-46,2
-24.59%		-21,3
-21,2
-0.2%		-13,6
-13,9
2.65%
-17,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-28,3
-16,9
-67.12%		-58,0
-46,6
-24.61%		-20,9
-21,5
2.87%		-7,60
-8,17
7.04%
-17,4

Net income
Million USD		Released
Forecast
Spread 		-38,6


-28,3
-16,9
-67.12%		-58,0
-46,3
-25.2%		-20,9
-21,5
3%		-7,60
-8,17
7.04%
-17,4

EPS
USD		Released
Forecast
Spread 		-342


-194
-6,75
-2766.67%		-61,8
-49,4
-25.1%		-19,8
-20,1
1.49%		-5,64
-6,00
6%
-10,8

Announcement Date27/03/2016/04/2128/03/2230/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-18,2
-6,84
-165.6%		-5,44
-7,45
26.95%		-3,01
-5,96
49.4%		-7,02
-3,83
-83.15%		-5,78
-5,73
-0.93%		-3,67
-5,70
35.7%		-3,62
-4,15
12.75%		-3,12
-3,95
20.96%		-3,17
-3,54
10.43%
-3,88


-4,21


-4,52


-4,81

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,0
-6,56
-174.68%		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%
-3,88


-4,21


-4,52


-4,81

Net income
Million USD		Released
Forecast
Spread 		-18,0
-6,73
-167.95%		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%
-3,88


-4,21


-4,52


-4,81

EPS
USD		Released
Forecast
Spread 		-15,6
-6,20
-151.61%		-5,10
-6,90
26.09%		-3,00
-5,40
44.44%		-6,60
-3,30
-100%		-5,40
-5,70
5.26%		-0,30
-4,80
93.75%		-1,50
-3,00
50%		-1,80
-3,00
40%		-5,52
-2,70
-104.44%
-2,70


-2,70


-2,70


-3,00

Announcement Date28/03/2216/05/2215/08/2231/10/2230/03/2315/05/2307/08/2301/11/2326/03/24----

Upcoming sector events for OXIS International, Inc.

Today 03:00 am HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement
Today 06:45 am PFIZER, INC.: Q1 2024 Earnings Release
Today 04:05 pm CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release
Today 04:05 pm JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release
2024-05-01 BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release
2024-05-01 AMGEN INC.: Q1 2024 Earnings Release
2024-05-02 01:30 am NOVO NORDISK A/S: Q1 2024 Earnings Release
2024-05-02 07:30 am ORGANON & CO.: Q1 2024 Earnings Release
2024-05-02 SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected)
2024-05-02 AARTI DRUGS LIMITED: Q4 2024 Earnings Release
More events

Past sector events for OXIS International, Inc.

Today 02:00 am GSK PLC: Q1 2024 Earnings Release
Today INNOVIVA, INC.: Q1 2024 Earnings Release (Projected)
Today PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
Today EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 06:25 am ELI LILLY AND COMPANY: Q1 2024 Earnings Release
2024-04-29 HAINAN POLY PHARM. CO., LTD: Q1 2024 Earnings Release
2024-04-29 SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-29 HARMONY BIOSCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release
2024-04-29 CATALENT, INC.: Q3 2024 Earnings Release (Projected)
2024-04-29 HAINAN HAIYAO CO., LTD.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. GTBP Stock
  4. Stock
  5. Calendar OXIS International, Inc.